This is an observational study to determine the efficacy and safety of vitamin-c in facial photodamage
Phase 4
Completed
- Conditions
- Health Condition 1: null- Facial photodamage
- Registration Number
- CTRI/2010/091/001161
- Lead Sponsor
- Cipla Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
1.Subjects willing to give written informed consent.
2.Subjects of either sex above 18 years of age.
3.Subjects with diagnosis of early to moderate photodamage
4.In the opinion of the investigator, able to comply with the requirements of the protocol.
Exclusion Criteria
1.Subjects with hypersensitivity to study drug or any of it?s excipients of its formulation.
2.Judged by Investigator to be inappropriate as subjects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change in Global clinical score for photodamageTimepoint: At week 4, 8 and 12 from baseline
- Secondary Outcome Measures
Name Time Method 1.Mean change in Patients self assessmentTimepoint: At week 4, 8 and 12 from baseline;2. Change in photographic assessmentTimepoint: At week 12 from baseline;3. Skin tolerability will be notedTimepoint: At week 12 from baseline;4. Incidence and nature of adverse eventsTimepoint: At week 12 from baseline;5. Incidence of drug related adverse reactionsTimepoint: At week 12 from baseline